Lansforsakringar Fondforvaltning’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$68M Buy
138,295
+17,438
+14% +$9.46M 0.36% 50
2025
Q4
$70M Buy
120,857
+2,495
+2% +$1.41M 0.35% 48
2025
Q3
$57.4M Buy
118,362
+1,652
+1% +$769K 0.3% 62
2025
Q2
$47.3M Sell
116,710
-6,995
-6% -$2.92M 0.27% 75
2025
Q1
$61.6M Sell
123,705
-3,187
-3% -$1.73M 0.38% 52
2024
Q4
$66M Buy
+126,892
New +$69.8M 0.37% 52

Other funds holding TMO

Lansforsakringar Fondforvaltning's TMO Position: Q1 2026 in Review

Lansforsakringar Fondforvaltning increased its Thermo Fisher Scientific (TMO) stake by 14% in Q1 2026, buying an estimated $9.46M and bringing the position to 138,295 shares worth $68M. The position accounts for 0.36% of the portfolio, ranked #50.

Lansforsakringar Fondforvaltning first reported a position in TMO in Q4 2024 and has held it in 6 quarters since. The position peaked at $70M in Q4 2025. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Lansforsakringar Fondforvaltning held 138,295 shares of Thermo Fisher Scientific worth $68M as of Q1 2026.
  • Lansforsakringar Fondforvaltning bought 17,438 Thermo Fisher Scientific shares in Q1 2026, an estimated $9.46M.
  • Thermo Fisher Scientific made up 0.36% of Lansforsakringar Fondforvaltning's portfolio in Q1 2026, its #50 holding.
  • Lansforsakringar Fondforvaltning first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 6 quarters since.
  • Lansforsakringar Fondforvaltning's Thermo Fisher Scientific position peaked at $70M in Q4 2025.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Lansforsakringar Fondforvaltning's 13F filing for Q1 2026, filed 23 Apr 2026.